Advanced Therapy Medicinal Products


Université de Genève (UNIGE)

Université de Lausanne (UNIL)

Lieu de formation

Lausanne (VD) - Berne (BE)

Langue d'enseignement


Type de formation

Hautes écoles universitaires HEU - Formation continue: formations longues

Modalités temporelles

À temps partiel

Thèmes de formation

Chimie, matières synthétiques, papier - Nature, sciences naturelles - Santé, soins, médecine

Domaines d'études

Médecine humaine - Sciences de la vie, biotechnologie


7.724.4.0 - 7.540.2.0

Mise à jour 28.03.2023


Description de la formation


  • Discover therapeutic advances in standardized transplants, cell-based products, blood products, complex and personalized medicines and innovative drug combinations
  • Acquire specialized knowledge of the different innovative therapies and their interaction with biological tissues
  • Understand the good manufacturing practices (GMP) required for these new types of medicines
  • Develop skills in quality control, quality assurance, and regulatory affairs
  • Understand the determinants of clinical applications of ATMPs and combinatorial therapies

This course is granted 16 ECTS credits.

Plan de la formation

The cursus implies :

Face-to-face teaching

  • Cellular therapy – from bench to bedside
  • Immunology
  • Transfusion medicine – science and technology from donor to patient
  • Combinatorial strategies in cancer treatment 
  • Oncology: innovative therapies
  • Phage therapy
  • Nanomedicines

Online teaching

Individual work


Conditions d’admission

  • Bachelor’s or master’s degree from a Swiss or foreign university (HEU), from a University of Applied Sciences (HES), or another title deemed equivalent
  • Minimum of 1 year of professional experience in the health care field

Admission on file.

Target audience

Healthcare professionals and scientists interested in the emerging field of advanced therapies, including pharmacists, physicians, medical researchers, biologists, healthcare engineers, biostatisticians.


CHF 6'000.-


  • Certificate of Advanced Studies CAS

CAS in Advanced Therapy Medicinal Products, delivered by the universities of Lausanne and Geneva

Infos pratiques

Lieu / adresse

  • Lausanne (VD)
  • Berne (BE)

Lausanne University Hospital
Blood transfusion center, Bern

Déroulement temporel

Début des cours


Durée de la formation

8 months.
392 hours of training.

Modalités temporelles

  • À temps partiel

Langue d’enseignement

  • anglais


Renseignements / contact

Academic questions: CAS.ATMP@unil.ch